1734 — Sinphar Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual balance sheet for Sinphar Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,194	1,245	1,244	1,081	1,178
Net Total Accounts Receivable
Net Total Receivables	469	593	685	643	642
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,540	2,703	2,778	2,649	2,624
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,321	3,247	3,204	3,278	3,316
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	6,127	6,221	6,185	6,251	6,298
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,330	1,534	1,446	1,205	1,423
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,382	3,499	3,255	3,153	3,035
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	2,744	2,722	2,930	3,098	3,263
Total Liabilities & Shareholders' Equity	6,127	6,221	6,185	6,251	6,298
Total Common Shares Outstanding